MCK
Price
$714.81
Change
+$2.66 (+0.37%)
Updated
Jul 30, 04:59 PM (EDT)
Capitalization
70.55B
6 days until earnings call
SHTDF
Price
$2.40
Change
-$0.00 (-0.00%)
Updated
Jul 22 closing price
Capitalization
9.79B
Interact to see
Advertisement

MCK vs SHTDF

Header iconMCK vs SHTDF Comparison
Open Charts MCK vs SHTDFBanner chart's image
McKesson
Price$714.81
Change+$2.66 (+0.37%)
Volume$4.23K
Capitalization70.55B
Sinopharm Group
Price$2.40
Change-$0.00 (-0.00%)
Volume$1K
Capitalization9.79B
MCK vs SHTDF Comparison Chart in %
Loading...
MCK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHTDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MCK vs. SHTDF commentary
Jul 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCK is a StrongBuy and SHTDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 31, 2025
Stock price -- (MCK: $714.92 vs. SHTDF: $2.40)
Brand notoriety: MCK: Notable vs. SHTDF: Not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: MCK: 131% vs. SHTDF: 77%
Market capitalization -- MCK: $70.55B vs. SHTDF: $9.79B
MCK [@Medical Distributors] is valued at $70.55B. SHTDF’s [@Medical Distributors] market capitalization is $9.79B. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MCK’s FA Score shows that 2 FA rating(s) are green whileSHTDF’s FA Score has 1 green FA rating(s).

  • MCK’s FA Score: 2 green, 3 red.
  • SHTDF’s FA Score: 1 green, 4 red.
According to our system of comparison, MCK is a better buy in the long-term than SHTDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MCK’s TA Score shows that 4 TA indicator(s) are bullish while SHTDF’s TA Score has 4 bullish TA indicator(s).

  • MCK’s TA Score: 4 bullish, 5 bearish.
  • SHTDF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MCK is a better buy in the short-term than SHTDF.

Price Growth

MCK (@Medical Distributors) experienced а +0.13% price change this week, while SHTDF (@Medical Distributors) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +2.06%. For the same industry, the average monthly price growth was +6.17%, and the average quarterly price growth was +2.06%.

Reported Earning Dates

MCK is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Medical Distributors (+2.06% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MCK($70.5B) has a higher market cap than SHTDF($9.79B). MCK has higher P/E ratio than SHTDF: MCK (24.25) vs SHTDF (8.00). MCK YTD gains are higher at: 25.708 vs. SHTDF (-3.614). SHTDF has higher annual earnings (EBITDA): 24.7B vs. MCK (4.44B). SHTDF has more cash in the bank: 43.5B vs. MCK (1.98B). MCK has less debt than SHTDF: MCK (7.61B) vs SHTDF (68.4B). SHTDF has higher revenues than MCK: SHTDF (521B) vs MCK (302B).
MCKSHTDFMCK / SHTDF
Capitalization70.5B9.79B720%
EBITDA4.44B24.7B18%
Gain YTD25.708-3.614-711%
P/E Ratio24.258.00303%
Revenue302B521B58%
Total Cash1.98B43.5B5%
Total Debt7.61B68.4B11%
FUNDAMENTALS RATINGS
MCK vs SHTDF: Fundamental Ratings
MCK
SHTDF
OUTLOOK RATING
1..100
7593
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
25
Undervalued
PROFIT vs RISK RATING
1..100
5100
SMR RATING
1..100
9957
PRICE GROWTH RATING
1..100
5254
P/E GROWTH RATING
1..100
4737
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MCK's Valuation (9) in the Medical Distributors industry is in the same range as SHTDF (25) in the null industry. This means that MCK’s stock grew similarly to SHTDF’s over the last 12 months.

MCK's Profit vs Risk Rating (5) in the Medical Distributors industry is significantly better than the same rating for SHTDF (100) in the null industry. This means that MCK’s stock grew significantly faster than SHTDF’s over the last 12 months.

SHTDF's SMR Rating (57) in the null industry is somewhat better than the same rating for MCK (99) in the Medical Distributors industry. This means that SHTDF’s stock grew somewhat faster than MCK’s over the last 12 months.

MCK's Price Growth Rating (52) in the Medical Distributors industry is in the same range as SHTDF (54) in the null industry. This means that MCK’s stock grew similarly to SHTDF’s over the last 12 months.

SHTDF's P/E Growth Rating (37) in the null industry is in the same range as MCK (47) in the Medical Distributors industry. This means that SHTDF’s stock grew similarly to MCK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MCKSHTDF
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
52%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 2 days ago
72%
Momentum
ODDS (%)
Bearish Trend 1 day ago
46%
Bullish Trend 2 days ago
58%
MACD
ODDS (%)
Bearish Trend 1 day ago
41%
Bullish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 2 days ago
54%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
38%
Bullish Trend 2 days ago
54%
Advances
ODDS (%)
Bullish Trend 1 day ago
66%
N/A
Declines
ODDS (%)
Bearish Trend 13 days ago
39%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
61%
Bearish Trend 2 days ago
58%
Aroon
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 2 days ago
54%
View a ticker or compare two or three
Interact to see
Advertisement
MCK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHTDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ILCG100.140.16
+0.16%
iShares Morningstar Growth ETF
LSGR42.810.06
+0.14%
Natixis Loomis Sayles Focused Growth ETF
EMPB28.830.04
+0.13%
Efficient Market Portfolio Plus ETF
NOVZ42.78N/A
N/A
TrueShares Structured Outcome Nov ETF
GDL8.32-0.07
-0.78%
GDL Fund (The)

SHTDF and

Correlation & Price change

A.I.dvisor tells us that SHTDF and SHTDY have been poorly correlated (+19% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHTDF and SHTDY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHTDF
1D Price
Change %
SHTDF100%
N/A
SHTDY - SHTDF
19%
Poorly correlated
+0.19%
COR - SHTDF
17%
Poorly correlated
+1.96%
SHPMY - SHTDF
12%
Poorly correlated
-0.74%
CAH - SHTDF
12%
Poorly correlated
+0.32%
AHG - SHTDF
10%
Poorly correlated
-5.34%
More